Winch Advisory Services’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-200
| Closed | -$3K | – | 476 |
|
|
2019
Q1 | $3K | Hold |
200
| – | – | ﹤0.01% | 304 |
|
|
2018
Q4 | $4K | Hold |
200
| – | – | ﹤0.01% | 252 |
|
|
2018
Q3 | $5K | Hold |
200
| – | – | ﹤0.01% | 236 |
|
|
2018
Q2 | $5K | Hold |
200
| – | – | ﹤0.01% | 235 |
|
|
2018
Q1 | $6K | Hold |
200
| – | – | ﹤0.01% | 217 |
|
|
2017
Q4 | $7K | Hold |
200
| – | – | ﹤0.01% | 204 |
|
|
2017
Q3 | $6K | Hold |
200
| – | – | ﹤0.01% | 202 |
|
|
2017
Q2 | $5K | Hold |
200
| – | – | ﹤0.01% | 222 |
|
|
2017
Q1 | $4K | Hold |
200
| – | – | ﹤0.01% | 215 |
|
|
2016
Q4 | $4K | Hold |
200
| – | – | ﹤0.01% | 198 |
|
|
2016
Q3 | $3K | Hold |
200
| – | – | ﹤0.01% | 222 |
|
|
2016
Q2 | $3K | Hold |
200
| – | – | ﹤0.01% | 215 |
|
|
2016
Q1 | $3K | Hold |
200
| – | – | ﹤0.01% | 183 |
|
|
2015
Q4 | $7K | Hold |
200
| – | – | 0.01% | 154 |
|
|
2015
Q3 | $6K | Hold |
200
| – | – | 0.01% | 151 |
|
|
2015
Q2 | $6K | Hold |
200
| – | – | ﹤0.01% | 200 |
|
|
2015
Q1 | $4K | Buy |
+200
| New | +$4K | ﹤0.01% | 212 |
|
|
2014
Q4 | – | Sell |
-200
| Closed | -$4K | – | 187 |
|
|
2014
Q3 | $4K | Buy |
200
+100
| +100% | +$2K | ﹤0.01% | 187 |
|
|
2014
Q2 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 224 |
|